| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | ESTRADIOL | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | ESZOPICLONE | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | AZITHROMYCIN | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | NeuroBion Tablets | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | NeuroBion Tablets | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use amlodipine besylate tablets, USP safely and effectively. See full prescribing information for amlodipine besylate tablets, USP. Amlodipine besylate tablets, USP for oral administration Initial U.S. Approval: 1987 | 7 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | SILDENAFIL | 1 | |
| Calcium Phosphate, Dibasic, Anhydrous | INACTIVE INGREDIENT | L11K75P92J | VP-Vite Rx | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use amlodipine besylate tablets USP safely and effectively. See full prescribing information for amlodipine besylate tablets USP. Amlodipine Besylate Tablets USP for oral administration Initial U.S. Approval: 1987 | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use azithromycin tablets safely and effectively. See full prescribing information for azithromycin tablets . AZITHROMYCIN tablets USP for oral use Initial U.S. Approval: 1991 | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | SUMATRIPTAN - sumatriptan succinate tablet | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | AZITHROMYCIN MONOHYDRATE | 5 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use VIAGRA safely and effectively. See full prescribing information for VIAGRA. VIAGRA® (sildenafil citrate) tablets, for oral use Initial U.S. Approval: 1998 | 4 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Fluconazole Tablets USP, for oral use rx only | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Somnapure Clinical Strength | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use Lisinopril Tablets USP safely and effectively. See full prescribing information for Lisinopril Tablets USP. LISINOPRIL Tablets USP, for oral use Initial U.S. Approval: 1988 | 3 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Cyclobenzaprine Hydrochloride Tablets USP Revised: January 2009 Rx only | 3 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | PENICILLIN V POTASSIUM TABLETS, USP PENICILLIN V POTASSIUM FOR ORAL SOLUTION, USP 1172 1174 4125 4127 | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Meclizine HCl Caplets USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Niva-Plus™ Tablets | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | CLONIDINE HYDROCHLORIDE TABLETS, USP | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Oral7 ® | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | BENZTROPINE MESYLATE TABLETS, USP 0.5 mg, 1 mg and 2 mg | 3 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use amlodipine besylate tablets USP safely and effectively. See full prescribing information for amlodipine besylate tablets USP. Amlodipine Besylate Tablets USP for oral administration Initial U.S. Approval: 1987 | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | BENZTROPINE MESYLATE TABLETS, USP 0.5 mg, 1 mg and 2 mg | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | WYMZYA™Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Lisinopril Tablets USP | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | CLONIDINE HYDROCHLORIDE TABLETS, USP | 3 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | b4189b86-b109-4828-9bcb-38e9dbc248db | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | SELECT-OB ® Prenatal Supplement | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Select Brand Maximum strength Laxative Pills | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Falessa Kit | 5 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Sertraline Hydrochloride Tablets USP 25 mg, 50 mg and 100 mg Rx Only | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | SELECT-OB ® Chewable Caplets Prenatal Supplement | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Drug Facts | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. AMLODIPINE besylate and BENAZEPRIL hydrochloride capsules for oral use Initial U.S. Approval: 1995 | 1000 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | 6368bb69-43e9-4304-a30d-03d593c1c05f | 4 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use CHANTIX safely and effectively. See full prescribing information for CHANTIX. CHANTIX® (varenicline) Tablets Initial U.S. Approval: 2006 | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use CHANTIX safely and effectively. See full prescribing information for CHANTIX. CHANTIX® (varenicline) Tablets Initial U.S. Approval: 2006 | 2 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Lisinopril and Hydrochlorothiazide Tablets | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Drug Facts | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | BENZTROPINE MESYLATE TABLETS, USP 0.5 mg, 1 mg and 2 mg | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use pravastatin sodium tablets USP safely and effectively. See full prescribing information for pravastatin sodium tablets USP. PRAVASTATIN SODIUM tablets USP for oral use Initial U.S. Approval: 1991 | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | 514d242d-48c9-4162-a85a-a433b41107ac | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | NaturVet ArthriSoothe Tablets | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | BENZTROPINE MESYLATE TABLETS, USP 0.5 mg, 1 mg and 2 mg | 2 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Lisinopril Tablets USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Amlodipine besylate tablets These highlights do not include all the information needed to use Amlodipine Besylate safely and effectively. See full prescribing information for Amlodipine Besylate. Amlodipine Besylate (Amlodipine Besylate) TABLET for ORAL use. Initial U.S. Approval: 2007 | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | ed2308e3-5310-41bd-9333-615c26183493 | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | c672cb8e-05a2-4ff5-b3bb-47acd955c2d9 | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Sertraline Tablets USP 25 mg, 50 mg and 100 mg Rx Only | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Promolaxin™ Docusate Sodium Stool Softener | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Paroxetine Tablets, USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | METOCLOPRAMIDE TABLETS, USP 2204 2203 | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Meclizine HCl Caplets USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL AND HYDROCHLOROTHIAZIDE USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Lisinopril Tablets USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Fluconazole Tablets USP | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use AMLODIPINE BESYLATE safely and effectively. See full prescribing information for AMLODIPINE BESYLATE. AMLODIPINE BESYLATE (AMLODIPINE BESYLATE) TABLET for ORAL use. Initial U.S. Approval: 1987 | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | ESTRADIOL TABLETS, USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | CLONIDINE HYDROCHLORIDE TABLETS, USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) Tablets Initial U.S. Approval: 2006 | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | ef0391c1-bbd8-400d-a8ab-add565df2d6c | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL and HYDROCHLOROTHIAZIDE TABLETS, USP | 6 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | FLUCONAZOLE Fluconazole Tablets Fluconazole for Oral Suspension | 13 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Amlodipine besylate tablets These highlights do not include all the information needed to use Amlodipine Besylate safely and effectively. See full prescribing information for Amlodipine Besylate. Amlodipine Besylate (Amlodipine Besylate) TABLET for ORAL use. Initial U.S. Approval: 2007 | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Promolaxin™ Docusate Sodium Stool Softener | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Paroxetine Tablets, USP | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | 4eadc265-78b3-473c-8a60-3f8e5c222dcf | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL TABLETS, USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | METOCLOPRAMIDE TABLETS, USP 2204 2203 | 2 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | HYDROCHLOROTHIAZIDE TABLETS, USP Rx only | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | HYDROXYZINE HYDROCHLORIDE TABLETS, USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Cyclobenzaprine Hydrochloride Tablets USP Revised: April 2013 Rx only | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | HYDROXYZINE HYDROCHLORIDE TABLETS, USP | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | ETODOLAC EXTENDED-RELEASE TABLETS 1122 7172 1118 Rx only | 2 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | CLONIDINE HYDROCHLORIDE TABLETS, USP | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | e04b0eb9-83b5-4b33-a1e7-1c1e84f0c897 | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | ACTIVE MOIETY | L11K75P92J | 05fc002c-b306-4e10-9b68-32c3c8a8bf0c | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ACTIVE INGREDIENT | L11K75P92J | 05fc002c-b306-4e10-9b68-32c3c8a8bf0c | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ACTIVE INGREDIENT | L11K75P92J | 8fa35893-0c7a-4c37-9107-3a74248feb65 | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | ACTIVE INGREDIENT | L11K75P92J | 8fa35893-0c7a-4c37-9107-3a74248feb65 | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | ACTIVE MOIETY | L11K75P92J | 8fa35893-0c7a-4c37-9107-3a74248feb65 | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ACTIVE INGREDIENT | L11K75P92J | 6487e3e4-2e2c-4383-aad6-277d156f363e | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | ACTIVE MOIETY | L11K75P92J | 6487e3e4-2e2c-4383-aad6-277d156f363e | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Lisinopril Tablets USP | 2 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Laxacin Laxative Plus Stool Softener | 2 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Buffered Aspirin For Medium to Large Dogs | 3 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | healthy mama PRENATAL VITAMINS | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Cyclobenzaprine Hydrochloride Tablets USP Revised: April 2013 Rx only | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Lisinopril Tablets USP | 4 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) Film-Coated Tablets, for oral use ISENTRESS ® (raltegravir) Chewable Tablets, for oral use Initial U.S. Approval: 2007 | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | 44a25c50-b16b-407c-99ea-668afca25924 | 4 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | dd372e00-c378-43bd-974c-f44f8adddb57 | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Drug Facts | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ACTIVE MOIETY | L11K75P92J | DR. RECKEWEG R34 Calcossin | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ACTIVE MOIETY | L11K75P92J | DR. RECKEWEG R11 Lumbagin | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ACTIVE MOIETY | L11K75P92J | DR. RECKEWEG R74 Nocturnin | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | 57d4729d-044f-4ed7-bc93-67c1af9df84c | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | 48a128ce-9279-4d39-b1eb-c4d2dd56f701 | 4 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Azithromycin Tablets USP, 250 mg and 500 mg 7146 7169 Rx only | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL TABLETS USP Once-Daily | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL TABLETS USP Once-Daily | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL TABLETS USP Once-Daily | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | GLYCOPYRROLATE TABLETS, USP Rx only | 3 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | Buffered Aspirin For Small Dogs | 3 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | WYMZYA TM Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg | 1 | |
| Calcium Phosphate, Dibasic, Anhydrous | ACTIVE INGREDIENT | L11K75P92J | PNV Prenatal Health™ - Prenatal Vitamins | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ACTIVE MOIETY | L11K75P92J | PNV Prenatal Health™ - Prenatal Vitamins | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL and HYDROCHLOROTHIAZIDE TABLETS USP Rx only | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | These highlights do not include all the information needed to use pravastatin sodium tablets USP safely and effectively. See full prescribing information for pravastatin sodium tablets USP. PRAVASTATIN SODIUM tablets USP for oral use Initial U.S. Approval: 1991 | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Imipramine Hydrochloride Tablets USP 10 mg, 25 mg, and 50 mg | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | Drug Facts | 4 | |